Bezalip Retard

Bezalip Retard is a medication containing bezafibrate, used to manage lipid levels and support cardiovascular health. This oral medication is designed for long-term use and is manufactured by Actavis Group Ptc Ehf.

Bezalip Retard is primarily used to lower lipid levels in the blood, including triglycerides and cholesterol. It is often prescribed for individuals with high cholesterol or triglyceride levels to help manage these conditions and support overall cardiovascular health. Bezafibrate works by increasing the breakdown of fats in the body, which can help reduce the risk of heart disease and other related conditions.

Common effects of Bezalip Retard may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may also experience muscle pain or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Bezalip Retard should be used with caution in individuals with liver or kidney disease. It is important to follow the prescribed dosage and not to exceed it without medical advice. Regular monitoring of liver function and lipid levels may be recommended during treatment.

Bezalip Retard may interact with other medications, including blood thinners, certain antibiotics, and other lipid-lowering drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited while using this medication.